! Recent advances to decode the genetics underlying inflammatory bowel disease (IBD) have led to the discovery of numerous IBD-associated genetic variants in the human genome. Our work studying these variants using genomics, mouse models, systems biology, and human patient samples has revealed the central role of autophagy and intracellular antimicrobial defense in the pathogenesis of IBD. In particular, characterization of IBD-associated I231L variant in the G protein-coupled receptor GPR65 revealed a key role of GPR65 as an environmental sensor that maintains lysosomal pH and function. Regulatory mechanisms that maintain lysosome homeostasis are critical in phagocytes such as macrophages, which require a highly developed lysosome network for delivery of microbicidal machinery to the phagosome. Recently, we have found that GPR65 interacts with the transcription factor, TFEB, that controls lysosome biogenesis. Here, we investigate the mechanisms by which GPR65 acts as a sensor, interpreting environmental cues and eliciting adaptive responses to maintain lysosomal homeostasis through TFEB.
In Aim 1, we examine the role of GPR65 in controlling lysosome homeostasis through signaling intermediates and TFEB transcriptional activity.
In Aim 2, we investigate the mechanisms by which impaired GPR65 signaling, and particularly the GPR65 I231L variant, results in colitis and pathogen susceptibility.
In Aim 3, we will define how endogenous metabolites regulate TFEB activity.
These research aims will advance our understanding of how metabolic sensors and lysosomal homeostasis mediate intracellular pathogen defense and could reveal a widespread role for lysosome biology in innate immunity.

Public Health Relevance

! Genetic studies have shown a polymorphism in the proton-sensing G-protein coupled receptor (GPR65 I231L) increases the risk of inflammatory bowel disease (IBD), a chronic condition that is currently incurable by medical or surgical interventions. Here, we investigate the mechanisms by which GPR65 acts as an environmental sensor to maintain lysosomal homeostasis through an interaction with TFEB, a transcription factor that controls lysosome biogenesis. This research project will help elucidate how metabolic sensors maintain lysosomal homeostasis, which has important implications for intracellular pathogen defense and innate immunity. !

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK117263-03
Application #
9879743
Study Section
Gastrointestinal Mucosal Pathobiology Study Section (GMPB)
Program Officer
Greenwel, Patricia
Project Start
2018-05-11
Project End
2022-02-28
Budget Start
2020-03-01
Budget End
2021-02-28
Support Year
3
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02114
Biton, Moshe; Haber, Adam L; Rogel, Noga et al. (2018) T Helper Cell Cytokines Modulate Intestinal Stem Cell Renewal and Differentiation. Cell 175:1307-1320.e22
Moretti, Francesca; Bergman, Phil; Dodgson, Stacie et al. (2018) TMEM41B is a novel regulator of autophagy and lipid mobilization. EMBO Rep 19: